Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1

por Rakha, E A, Pinder, S E, Paish, C E, Ellis, I O
Publicado 2004

Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer

por Mukherjee, A, Shehata, M, Moseley, P, Rakha, E, Ellis, I, Chan, S
Publicado 2010

Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level

por Atallah, N. M., Alsaleem, M., Toss, M. S., Mongan, N. P., Rakha, E.
Publicado 2023

The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis

por Roxanis, I., Colling, R., Kartsonaki, C., Green, A. R., Rakha, E A.
Publicado 2018

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype

por Elsheikh, S E, Green, A R, Rakha, E A, Samaka, R M, Ammar, A A, Powe, D, Reis-Filho, J S, Ellis, I O
Publicado 2008

Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer

por Rakha, E A, Soria, D, Green, A R, Lemetre, C, Powe, D G, Nolan, C C, Garibaldi, J M, Ball, G, Ellis, I O
Publicado 2014

KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer

por Alshareeda, A T, Negm, O H, Green, A R, Nolan, C C, Tighe, P, Albarakati, N, Sultana, R, Madhusudan, S, Ellis, I O, Rakha, E A
Publicado 2015

Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research

por Rea, D, Francis, A, Hanby, A M, Speirs, V, Rakha, E, Shaaban, A, Chan, S, Vinnicombe, S, Ellis, I O, Martin, S G, Jones, L J, Berditchevski, F
Publicado 2015

Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study

por Rakha, E A, Tan, P H, Varga, Z, Tse, G M, Shaaban, A M, Climent, F, van Deurzen, C H M, Purnell, D, Dodwell, D, Chan, T, Ellis, I O
Publicado 2015

Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers

por Green, A R, Powe, D G, Rakha, E A, Soria, D, Lemetre, C, Nolan, C C, Barros, F F T, Macmillan, R D, Garibaldi, J M, Ball, G R, Ellis, I O
Publicado 2013

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response

por Al-kaabi, M M, Alshareeda, A T, Jerjees, D A, Muftah, A A, Green, A R, Alsubhi, N H, Nolan, C C, Chan, S, Cornford, E, Madhusudan, S, Ellis, I O, Rakha, E A
Publicado 2015

Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer

por Green, Andrew R., Soria, D., Powe, D. G., Nolan, C. C., Aleskandarany, M., Szász, M. A., Tőkés, A. M., Ball, G. R., Garibaldi, J. M., Rakha, E. A., Kulka, J., Ellis, I. O.
Publicado 2016

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2

por Wishart, G C, Bajdik, C D, Dicks, E, Provenzano, E, Schmidt, M K, Sherman, M, Greenberg, D C, Green, A R, Gelmon, K A, Kosma, V-M, Olson, J E, Beckmann, M W, Winqvist, R, Cross, S S, Severi, G, Huntsman, D, Pylkäs, K, Ellis, I, Nielsen, T O, Giles, G, Blomqvist, C, Fasching, P A, Couch, F J, Rakha, E, Foulkes, W D, Blows, F M, Bégin, L R, van't Veer, L J, Southey, M, Nevanlinna, H, Mannermaa, A, Cox, A, Cheang, M, Baglietto, L, Caldas, C, Garcia-Closas, M, Pharoah, P D P
Publicado 2012